Bob Warnock Email & Phone Number

Raleigh-Durham-Chapel Hill Area

Leading clinical and non-clinical biostatistics functions for vaccines and medical countermeasures

Raleigh, North Carolina, United States

Leading early and late phase client biostatistics and programming needs

Raleigh-Durham-Chapel Hill Area

Global Product Statistician supporting Inhaled Symbicort and Established Brands Franchise for inhaled respiratory products.

Raleigh-Durham, North Carolina Area

Develop and manage studies linking primary healthcare data (prospective clinical trial data) and secondary sources (EHR, administrative claims data) to create enriched studies that enhance drug development programs.

Raleigh-Durham, North Carolina Area

Manage team of statisticians and programmers to deliver development portfolio and support late stage lifecycle development for all statistical aspects of late phase Neurology drug development (Epilpesy, Parkinson’s Disease and Restless Legs Syndrome), including post-marketing clinical decision support tools using claims and EHR predictive algorithms.

Raleigh-Durham, North Carolina Area

Oversee advanced analytics methods development (Predictive modeling, machine learning methods, etc.) and observational data analysis (retrospective database studies, economic endpoints and patient reported outcomes) across all aspects of clinical development.

RTP, NC

Manage program statisticians overseeing all aspects of Phase II-IV clinical development and oversee observational data analysis to support the analysis of retrospective database studies, pharmacoeconomic endpoints and patient reported outcomes.

Durham, NC

Statistical lead for all adult, primary generalized tonic-clonic (PGTC) studies across 2 compounds

San Antonio, Texas Area

Manage in-house programming staff and responsible for all statistical aspects of myelodysplastic syndrome product development, including clinical development plans, protocol and CRF development

Durham, NC

Responsible for all statistical aspects of Phase II-IV epilepsy development (2 compounds), including clinical development plans, product profiles, protocol and CRF development, abstracts, publications and submissions worldwide

Richmond, Virginia Area

Built a biostatistics and programming department to database and support all current and previous studies for the Diabetes and Polycystic Ovary Syndrome indications currently in Phase II

Mountain View CA

Generated audit plans and processes for monitoring several data management and statistical CROs (8 studies across 5 programs), reviewed statistical analysis and data management plans for accuracy and completeness as well as CRF and protocol development for Phase I – III studies

Bloomingdale IL And San Diego CA

Managed project teams of statisticians and statistical programmers; produced analysis plans and performed statistical analyses evaluating safety and effectiveness across a variety of therapeutic areas

Ms, Statistics

Bs, Economics